Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4348181 | 0.92 | BDKRB1 (0.52) | BDKRB1 | |
| SCHEMBL4345057 | 0.89 | BDKRB1 (0.44) | BDKRB1AOC3 | |
| SCHEMBL4344847 | 0.83 | BDKRB1 (0.41) | BDKRB1AOC3 | |
| SCHEMBL4345307 | 0.81 | BDKRB1 (0.38) | BDKRB1AOC3 | |
| SCHEMBL4345303 | 0.78 | NPC1 (0.39) | BDKRB1AOC3 | |
| SCHEMBL4356188 | 0.78 | AVPR1A (0.36) | BDKRB1AOC3 | |
| SCHEMBL4353756 | 0.76 | AOC3 (0.38) | BDKRB1AOC3 | |
| SCHEMBL700704 | 0.74 | BDKRB1 (0.46) | BDKRB1 | |
| SCHEMBL4353803 | 0.73 | RAB9A (0.38) | AOC3 | |
| SCHEMBL4091558 | 0.70 | BDKRB1 (0.54) | BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8268814-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2012-09-18 | — | — | US | claimed |
| US-20090275558-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS | GRUENENTHAL GMBH (DE) | 2009-11-05 | — | — | US | claimed |
| US-8268814-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2012-09-18 | — | — | US | disclosed |
| US-20090275558-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS | GRUENENTHAL GMBH (DE) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275558-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS | BDKRB2, BDKRB1, TRPV1 | BDKRB1 2/4885AOC3 4024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.